Dofetilide

Ferences were found in self-reported experience of side effects. What does emerge clearly is that NET-EN is viewed as the product of choice for young women and DMPA for older women. This is reflected in reasons given for product preference by clients, and in the age distribution of DMPA and NET-EN users. Further, health workers appear to play an important role in decisionmaking about which IPC product is provided. That different products are considered to be more appropriate for different age groups may be linked to the perception that DMPA is "stronger" while NET-EN is "weaker", and may well be related to concerns about delay in return to fertility after IPC use, particularly with DMPA. This is consistent with results from a study undertaken in the Northern Province of South Africa where providers were found to recommend NET-EN for younger women based.
On June 15, Enrique Modesto was one of the parents demonstrating in front of a , 000 a ticket fundraiser for Speaker Miller in the West Village. Miller, who has received substantial contributions from real-estate interests, is likely to run for mayor in 2005. The picket, called by NYCCELP was an attempt, in the , words of radical historian Howard Zinn, to "demand access in other ways." Sure, parents and advocates couldn't afford the price of admission to the gathering--but they had a message to impart, nonetheless. PACC's report on lead hazards in Bed-Stuy is available on-line at prattarea leadpaint . For more information on the New York City Coalition to End Lead Poisoning and to join their campaign for Intro 101a, contact Maureen Silverman at 212 ; 543-0260 Ext. 204, or go to their Website, nyccelp. Figure 2 Results of acute phase treatment, based on response to programmed electrophysiological stimulation. patients. Ten four dofetilide and six sotalol ; of these discontinuations were drug- related. One patient in each group was discontinued for lack of efficacy. Three patients receiving dofetilide developed torsade de pointes. Two patients receiving sotalol died. Sotalol was discontinued in one patient each for dizziness, syncope, and a combination of asthma and leg oedema. During the acute phase, 11 of the 128 patients 86% ; who received dofetilide experienced at least one all-causality adverse event compared with 25 of the 128 patients 195% ; who received sotalol P 0002; CI 0173 0043 ; . These adverse events were deemed to be treatment related in three 23% ; patients receiving dofetilide and 11 86% ; patients receiving sotalol P 0016 ; . Excluding objective test findings, in the acute phase adverse events were reported with a lower prevalence for dofetilide seven patients; 5% ; compared with sotalol 23 patients; 18% ; . Dizziness one patient; 08% ; was the only drug related adverse event reported by patients receiving dofetilide. Dizziness was also the most common adverse event reported by the patients during treatment with sotalol five patients; 38% ; . Additional adverse events reported by patients receiving sotalol were: severe asthaenia, nausea, headache, hypotension, heart failure and peripheral oedema. As previously noted, sotalol treatment was discontinued in three patients secondary to reported symptoms.
Fig. 7. Effects of dofetilide at 4.2 M on WT and three mutant Y649A, Y652A, S624A ; hERG channel currents. Besides tumors and shows prolonged concentration in the blood. For these reasons we may suppose that.
We made quality-of-life adjustments for influenza illness on the basis of data collected from elderly patients by using the EuroQOL instrument 33 ; . Short-term morbidity is expressed on a scale from 0, indicating no effect on quality of life, to 1, indicating a complete loss of quality for each day of illness. In the sensitivity analysis, we tested the full range for each possible health state. We used a societal perspective in keeping with the recommendations of the Panel on Cost-Effectiveness in Health and Medicine 39 ; . Thus, we considered direct medical costs, including physician office visits, diagnostic tests, medications, and hospitalizations. We assumed that patients would not be employed, and thus, we did not include lost wages. Physician fees were based on a moderate-complexity office visit for an established patient 35 ; . We used the retail price provided from the manufacturer for the rapid diagnostic test. Medication costs were average wholesale prices. Hospitalization costs were based on geriatric patients hospitalized for influenza at 75 hospitals 25 ; . All costs were updated to 2001 U.S. dollars by using the medical care component of the Consumer Price Index 40 and dok.
Neilson Nelson ; , Adam, farmer in Stonelaws, in the parish of Whitekirk, and Kaithren Shirriff in Kirklandhill 29 July 1780 Alexander, sailor, and Isabell Beath, daughter of Alexander Baith, mason 7 Nov. 1786 Christina, daughter of the deceased John Neilson, and John Hume, soldier in the. 41st Regment 21 Mar. 1792 Mr. David, merchant, and Miss Ann Renton, daughter of the late James Renton, residenter 23 Dec. 1799 Henry, wright, and Margaret Robertson 25 Nov. 1738 James, soapboiler, and jean Dudgeon 10 Sept. 1786 Jean, laufull daughter to the deceast Alexander Neilson, merchant in Linlithgow, and John Thomson, mason in the parish of Tranent 7 April 1719 John, labourer, and Margaret Stuart, indweller in the Abbay 8 Dec. 1764 John, tailor, and Margarate Mack, daughter of Peter Mack ; witness, John La ndles 10 May 1793 Johne, and Bessie Davidsun mar. about 20 Aug. 1567 John, and Suse Puirddy mar. about 20 Aug. 1567 Mattheu, soldier in 23rd Regiment of Light Dragoons, and Elspit King, daughter of John King, residenter in Edinburgh 17 Dec. 1795 Janet, and James Keir mar. about 20 Aug. 1567 Margaret, and James M'Rankein from Maybole m. Thursday, 15 Oct. 1646 Margaret, servant to Andrew Johnston, indweller in the Abbey, and George Anderson, soldier in Lee's Regiament in Aimer's Company 17 Sept. 1743 Margaret, daughter of John Neilson, weaver in Silver Mills, and Richard Burrel, mariner in the Appolo Frigat 23 Oct. 1798 Margaret, daughter of John Neilson, wright in Edinburgh, and Robert Laidlaw, upholsterer 12 Sept. 1806 Robert, and Bessie Davidson 15 June 1566 William, and Marjorie Andersone m. 9 June 1646 Neilsone ; , William, servitour to the Duchess of Hamiltoune, and Jonet Broune, servitrix to John Auchinlock, wright, burges p. 28 Oct., m. 21 Nov. 1695 - , daughter of the deceased Neilson, and Thomas Boog, surgeon 27 April 1786 Neish, Thomas, mason, and Jean Crooks, daughter of William Crooks, labourer in Belhaven 28 Aug. 1795 Nemanners , Robert, wright, and Mary Barclay, servant to Alexander M'Dougall, merchant in Edinburgh 25 Nov. 1718 Ness, Ann, daughterof Thomas Neiss, tailor in Shetland, and William Conyers, hatter 12 Nov. 1798 Euphemia, daughter of James Ness, wright in Achtermuchty, and David Cree, shoemaker 24 April 1787 John, tailor, and Janet Lendells 6 June 1714 Mary, indweller, and John Schaw 7 Dec. 1764. Nausea and vomiting Most people have little nausea. Continue drinking clear fluids. Get fresh air and rest. See Nausea and Vomiting pamphlet. Phone your doctor if vomiting lasts more than 24 hours or nausea longer than 48 hours. Apply cool compresses or soak in cool water for 15 20 minutes several times a day Protect area from heat and light and dolasetron.

Patient had been in a supine position for 10 min. Mean arterial pressure MAP ; was calculated from diastolic pressure plus one-third of the pulse pressure. Blood samples were obtained from an antecubital vein. The haematocrit was analysed by micro-haematocrit centrifugation at 11 000 g for 5 min without correction for trapped plasma. Within 20 min after blood collection, the haemorheological variables were assessed at 37C in a Low Shear 30 rotational viscometer Contraves AG, Zurich, Switzerland ; . Plasma viscosity was analysed at a shear rate of 38 s-1 and apparent whole blood viscosity at 100 s-1 at native haematocrit. As proposed by the International Committee for Standardization in Haematology [11], erythrocyte aggregation tendency was assessed as whole blood viscosity at native haematocrit at a shear rate of 1 s-1 and corrected for haematocrit and plasma viscosity. The unit for erythrocyte aggregation is dimensionless. Erythrocyte deformability was assessed as the fluidity inverse viscosity ; of red blood cells separated from plasma and buffy coat and resuspended in isotonic phosphatebuffered saline pH 7.4 ; to a haematocrit of 55%. A shear rate of 1 s-1 was used. Plasma fibrinogen was determined by rate nephelometry. Other biochemical variables were analysed using standard laboratory techniques for hospital use. Mitosis, HL-1 cells remained attached to adjacent cells via intercalated discs Fig. 1 f, g, and i ; and contained peripheral myofibrils consisting of partial sarcomeres lacking definitive Z lines Fig. 1g ; . These characteristics also are seen in cultured cardiomyocytes and in mitotically active atrial cardiomyocytes in situ. Gene Expression in the HL-1 Cell Line. To characterize the HL-1 cell line in terms of the cardiac-specific genes that it expresses and as a further assessment of its differentiated phenotype, Reverse transcriptionPCR RT-PCR ; -based analyses were used. Contractile protein isoform expression is a well-established index of the developmental and differentiated state of cardiomyocytes. As shown in Fig. 2, HL-1 cells expressed the adult isoform of MHC -MHC ; whereas the control embryonic ventricle ; expressed only the embryonic isoform of myosin -MHC ; . Cultured HL-1 cells also expressed -cardiac actin similar to adult mouse ventricle cells. In addition, HL-1 cells expressed transcripts for ANF and connexin43 the major protein of the adult gap junction ; . This RT-PCR analysis demonstrated that the pattern of gene expression of cultured HL-1 cells was similar qualitatively to that of adult atrial cardiomyocytes. Electrophysiological Characterization. After several days in culture, HL-1 cells exhibited spontaneous action potentials not shown ; and synchronous beating in confluent cultures. We used the whole-cell mode of the patch-clamp technique to identify the repolarizing K currents present in HL-1 cells. Depolarizing voltage clamp pulses activated a time-dependent outward current Fig. 3A ; . The time-dependent activating current displayed inward rectification Fig. 3C ; for depolarizing pulses positive to 0 mV. Deactivating current tails were voltage-dependent and saturated between 20 mV and 30 mV Fig. 3 A and C ; . The deactivation kinetics of the tail current were biexponential. These properties are similar to the current IKr, a delayed rectifier K current characteristic of cardiac myocytes. IKr-like current was the most prominent outward current in HL-1 cells and was found in 61 of cells examined. The time-dependent activating currents and deactivating tail currents were highly sensitive to the methanesulfonanilide, dofetilide Fig. 3 B and D IC50 of 46.9 nM n and doral. Methods: dogs aged 1– 150 days and adults were used to study 1 ; proarrhythmic effects in situ of the i kr blocker dofetilide; 2 ; dofetilide effects on action potential duration apd ; recorded with microelectrodes from left ventricular lv ; slabs; 3 ; i kr and i ks in single lv myocytes using whole-cell voltage clamp. Fig. 2. Cellular and ionic disorders in myocytes isolated from IDDM rabbits. A: prolongation of action potential AP ; duration APD ; in IDDM rabbits. Left: analog ADP data recorded from single ventricular myocytes. Right: APD at 50% and 90% repolarization APD50 and APD90, respectively ; . Values are means SE n 12 cells from 5 rabbits ; . * P 0.05 vs. Ctl. P 0.05 vs. IDDM. B: depression of rapid delayed rectifier K current IKr ; in IDDM rabbits. Left: cell capacitance-normalized traces of dofetilide 1 M ; -sensitive IKr recorded from isolated ventricular endocardial myocytes. Inset: voltage protocols. Right: current density as a function of testing potential. Values are means SE of number of cells from 5 hearts shown in parentheses. * P 0.05 vs. Ctl and dovonex.

A protocol for the initiation of dofetilide has been implemented and is in compliance with the manufacturer's imposed regulations see figure 1. The present study is the first of which we are aware that compares the ionic properties of atrial myocytes from the LA with those from the RA, relating ionic differences to AP properties at the single cell and multicellular level and also to ERP in vivo. Thus, our findings add potentially important information regarding ionic mechanisms of interatrial electrophysiological variation. The treatment of AF remains suboptimal. An improved understanding of the fundamental basis of atrial electrophysiological function should help in the development of improved therapeutic approaches. We have recently shown that intravenous dofetilide increases ERP to a greater extent in the LA than in the RA in dogs with a substrate for AF caused by either congestive heart failure or sustained atrial tachycardia.21 Dofetilide was highly effective in terminating heart failurerelated AF but was relatively ineffective in AF associated with atrial tachycardiainduced remodeling. In the latter group, dofetilide largely eliminated reentrant activity in the LA, but persistent reentry in the RA maintained AF. The findings of the present study may explain, at an ionic level, why dofetilide is more effective in prolonging canine atrial ERP and preventing atrial reentry in the LA than in the RA. Our results may also relate to recent studies of surgical therapy for AF that point to a role for the LA as a critical driver region for the arrhythmia.22, 23 and dronabinol. Key Words: Obesity, metabolic syndrome, nuclear receptor, PPAR's, food intake, energy expenditure. INTRODUCTION For many years there was a widespread opinion that obesity is just a consequence of lifestyle. Extensive research in the obesity area in the last decade started to alter this view. Now, the majority of medical professionals not only consider obesity to be a disease but also accept the fact that obesity can lead to the development of other diseases. Most important among them are: diabetes [1], hypertension [2, 3], renal disease [2, 3], increased mortality in cancer patients [46] and joint problems [7]. Epidemiological estimates of the aggregate economic costs associated with specific obesityrelated diseases in the United States indicate that the annual burden to society totals in the billions of dollars, representing 5.5% to 7.8% of total health-care expenditures [8]. In 2002 the Diabetes Prevention Program Research Group published results of multiyear studies demonstrating that lifestyle changes comprised of a low calorie diet and exercise aimed at 7% weight reduction were more effective in preventing and controlling diabetes than treatment with metformin or placebo [9]. The lifestyle change group had lower incidence of new diabetes cases and lower HbA1c than the metformin and placebo groups over a 4 years period. Data from numerous studies provide evidence that weight loss has beneficial effects on blood pressure [10-13]. Even modest weight loss of 3-9% significantly lowered both systolic and diastolic pressure by 3 mmHg. Treatment of obese hypertensive patients with orlistat for 52 weeks led to. University of Florida Tropical Research and Education Center Homestead, FL 33031-3314, U.S.A and dss.

Between 6% and 9.6% of patients treated with long-term ximelagatran develop a 3-fold or greater increase in alanine aminotransferase.41, 42, 93, 94 Typically, this side effect occurs between 6 weeks and 6 months of treatment.41, 42, 93, 94 The increase in alanine aminotransferase is usually asymptomatic and reversible, even if the medication is continued. Based on data from clinical trials, the increase in transaminases with ximelagatran has been benign. However, this side effect is of potential concern and, if the drug is approved, its.
TIKOSYN's efficacy in the treatment of chronic or persistent AF was evaluated in 2 large multicenter trials. Specifically, the ability to convert patients with AF or AFL of more than 1 week duration to NSR and the ability to maintain NSR delay in time to recurrence of AF AFL ; after drug-induced or electrical cardioversion for up to 12 months was evaluated. The maintenance of NSR was measured in 3 ways: 1 ; the probability of remaining in NSR at 6 and 12 months, 2 ; the percentage of patients who were in NSR and still on treatment at 6 and 12 months, and 3 ; the time to relapse to AF. Entry into the trials was limited to those patients who had documented target arrhythmia, no excessive QT prolongation, AV block, or bradycardia. Patients were excluded if there was evidence of acute MI, unstable angina, unstable CHF, reversible causes of the target arrhythmia, or history of polymorphic ventricular tachycardia PMVT ; associated with QTprolonging agents. European and Australian Multicenter Evaluative Research on Atrial Fibrillation and Dofetilide EMERALD ; This large-scale, placebo-controlled, randomized, 12-month study, the European and Australian Multicenter Evaluative Research on Atrial Fibrillation and Dofetilide EMERALD ; , compared TIKOSYN 500, 250, and 125 mcg administered twice daily with placebo in 534 patients with a primary diagnosis of AF and or AFL persisting for up to 2 years. Patients' initial doses were adjusted for creatinine clearance CLCr ; and subsequent doses could be adjusted downward according to QTc response to therapy. In all patients, treatment with TIKOSYN was initiated in the hospital. Patients were hospitalized for the initiation of blinded therapy and had continuous electrocardiographic monitoring during this phase Fig 6 and dulcolax and dofetilide. FFF-based identification of serine hydrolase functional sites FFFs were developed to identify functional sites in protein structures 15 ; . One of the most powerful aspects of the FFF technology is its ability to identify functional sites accurately in both experimentally determined and computationally modeled protein structures 41 ; . Another advantage of the FFF technology is that it does not rely on function annotation transfer based on global sequence alignment. Key functional residues are specifically identified in the protein structure, regardless of overall global sequence similarity to any other protein exhibiting the same function. This feature has allowed identification of similar functional sites in proteins with different overall architectures and low overall sequence similarity 56, 57 ; . For this study, FFFs were created to describe and identify the diversity of serine hydrolase functional sites such as the examples in Figure 1 ; . A common feature of these FFFs is the inclusion of a nucleophilic or active serine. The library utilized in this study contained 35 different serine hydrolase FFFs, including six composite FFFs Table 1 ; . Composite FFFs are. As a member of the Settlement Group, you may object to the Proposed Settlement, enter an appearance in this matter through counsel, What is BuSpar? or appear at the final approval hearing and duragesic.
Tion ; and pursue the appropriate work-up to rule out lifethreatening and reversible causes. The second task is to better understand his or her own reactions and those of other staff ; to the patient. Negative reactions by medical and nursing staff a component of countertransference ; often prevent patients from receiving appropriate care. By understanding the source of these reactions and formulating strategies to combat them, staff can provide patients the care they require in a more satisfying and professional manner. Last, given the growing cultural and ethnic diversity of both medical staff and patient populations, it is important for caregivers to be cognizant of the way in which their colleagues and patients relate to nakedness; we need to foster an atmosphere where everyone can feel comfortable providing and receiving care. Cutaneous propionibacterial isolates were collected from the faces of acne patients and dermatologists at clinics in Leeds UK ; , Ferrara Italy ; , Uppsala Sweden ; , Kecskemet Hungary ; , Athens Greece ; and Malaga Spain ; . Swabs were plated directly onto TYEGF plates containing erythromycin 0.5 mg L.

Wright's-Giemsa staining. For these microscopic studies, a single colony was removed from the plate under a. Anscher MS and Vujaskovic Z, Mechanisms and Potential Targets for Prevention and Treatment of Normal Tissue Injury after Radiation Therapy. Semin Oncol 32, 2 Suppl 3: S86-91, 2005. PubMed link Robbins ME and Zhao W, Chronic Oxidative Stress and Radiation-Induced Late Normal Tissue Injury: A Review. Int J Radiat Biol 80, 4: 251-259, PubMed link Dent P, Yacoub A, Contessa J, et al., Stress and Radiation-Induced Activation of Multiple Intracellular Signaling Pathways. Radiat Res 159, 3: 283-300, PubMed link Williams J, Chen Y, Rubin P, et al., The Biological Basis of a Comprehensive Grading System for the Adverse Effects of Cancer Treatment. Semin Radiat Oncol 13, 3: 182-188, PubMed link Denham JW and Hauer-Jensen M, The Radiotherapeutic Injury--a Complex 'Wound'. Radiother Oncol 63, 2: 129-145, PubMed link. In the treatment arm 19% complete response, 10% partial response ; and 2% in the placebo arm P .001 ; . Pain during the injection was the most common adverse event: 24% of patients in the treatment arm and 17% in the placebo arm experienced pain within 15 to 20 minutes. Local toxic effects, including inflammation, bleeding, erosion, ulceration, necrosis, and eschar, occurred in 87.4% of patients in the treatment arm and 62.7% in the placebo arm. Other adverse effects included wound infection in 5.9% vs 1.7% and fistula formation in 3.3% vs 0% for patients in the treatment arm vs placebo arm, respectively. Four cases of treatment-related cerebrovascular events 3 in the treatment arm and 1 in the placebo arm ; were observed. After implementation of an amendment to exclude patients with tumors that directly involved or threatened to invade the carotid artery, no further cerebrovascular events related to treatment were reported. In clinical trials using IT docetaxel, we also expect no significant systemic toxic effects thanks to lower plasma concentrations ; and no cerebrovascular events because no epinephrine will be involved ; . In the present study, docetaxel's mechanisms of action at supradose levels with respect to cell cycle regulation, apoptosis, and signal transduction were examined. In a future study, we are planning a detailed histologic and protein expression analysis using immunohistochemical analysis, since only in vitro studies were performed in this pilot study. The docetaxel-induced altered protein expression pattern of cell cycle regulators cyclin A, cyclin B, p21, and p27 ; and signal transduction molecules EGFR, pEGFR, pc-Jun, and pERK ; was and dok.
Dofetilide may cause torsades de pointes and the patients should be monitored very closely in hospital for the first few days to pick up the proarrhythmic effects.
Mulation syndromes, such as buffalo hump and abdominal visceral organ ; fat buildup. Finally, a recent report from Paris has discussed using a testosterone derivative called Andractim or DTH dihydrotestosterone ; topically for gynecomastia. The report is not clear whether the breast enlargements being treated with this modality is due to fat accumulation or is of hormonal origin. Conclusion One would hope that one never has to face breasts against one's will! However, with the evolving field and treatment of HIV and its related complications, breast tissue can emerge as a challenge for both patients and their physicians. The widespread use of hormonal agents to combat hypogonadism and wasting has added to the frequency of gynecomastia. Alternatively, lipodystrophy has increased fatty breast tissues in some HIV-positive individuals. Patients should be aware of treatment options, as well as the risks of using and over-abusing testosterone. Holidays from hormonal replacement treatment are encouraged and anti-estrogens can improve and avert the onset of gynecomastia. As mentioned in many of my articles, discussing treatments mentioned in this column with your personal physician is always prudent. I encourage comments and questions. e Daniel S. Berger, MD is Medical Director of NorthStar Healthcare and Clinical Assistant Professor of Medicine at the University of Illinois at Chicago and editor of AIDSInfosource aidsinfosource ; . He also serves as medical consultant for Positively Aware. For further inquiries Dr. Berger can be reached at DSBergerMD aol or 773 ; -296-2400. DR LOVE: In your practice in these kinds of situations, do you offer patients specific numbers about their risk of recurrence and how that's affected by therapy? A lot of people use Peter Ravdin's Adjuvant! Online model Olivotto 2005 ; . Do you generally use that? MS LUKE: My colleague and I use Adjuvant! Online, and we went through that process with this patient. DR LOVE: Gary, globally, for a patient with one positive node and ER PR-positive, HER2-negative disease, what would you roughly calculate the risk for recurrence to be, and how might that be affected by chemotherapy and hormonal therapy? DR LYMAN: Although it's just barely a T1 tumor, there is a positive node, and she is clearly at risk, and we would want to offer her adjuvant options.
5.4g continued from previous page In recent onset AF of less than 90 days, IV ibutilide is more effective than placebo and IV procainamide. In chronic AF, oral dofetilide converts AF to NSR within 72 hours, and oral propafenone and amiodarone are effective after 30 days of therapyi. The authors concluded that for conversion of recent onset AF of less than seven days, procainamide may be considered a preferred IV agent and propafenone a preferred oral agent. For conversion of recent-onset AF of longer duration less than 90 days ; , IV ibutilide may be considered a preferred agenti. The second set of reviewers found that, although multiple antiarrhythmic agents had strong evidence of efficacy compared with control treatment for the maintenance of sinus rhythm, ibutilide dofetilide and flecainide had particularly strong evidence of efficacy compared with control treatment for AF conversionii. Compared with control treatment placebo, verapamil, diltiazem, or digoxin ; , the odds ratio OR ; for conversion was greatest for ibutilide dofetilide OR 29.1; 95% confidence interval [CI], 9.8-86.1 ; and flecainide OR 24.7; 95% CI 9.0-68.3 ; . Less strong but conclusive evidence existed for propafenone OR 4.6; 95% CI 2.6-8.2 ; . Quinidine OR 2.9; 95% CI 1.2-7.0 ; had moderate evidence of efficacy for conversion. Disopyramide OR 7.0; 95% CI 0.3-153.0 ; and amiodarone OR 5.7; 95% CI 1.0-33.4 ; had suggestive evidence of efficacy. Sotalol OR 0.4; 95% CI 0.0-3.0 ; had suggestive evidence of negative efficacy. For MSR, strong evidence of efficacy existed for quinidine OR 4.1; 95% CI 2.5-6.7 ; , disopyramide OR 3.4; CI 1.6-7.1 ; , flecainide OR 3.1; 95 % CI 1.5-6.2 ; , propafenone OR 3.7; 95% CI 2.4-5.7 ; , and sotalol OR 7.1; 95% CI 3.8-13.4 ; . The only amiodarone data, from comparison with disopyramide, provided moderate evidence of efficacy for MSR. No trial evaluated procainamide. Direct agent comparisons and adverse event data were limitedii. Caveat: Ibutilide and dofetilide are not available in the UK.